Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ETS1 - Periodontal therapy effect on peripheral blood monocytes: time course
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ETS1 - Relapsing-remitting multiple sclerosis therapy of Interferon-β Betaferon or Rebif: peripheral mononuclear blood cells
ETS1 - Breast tumor-derived stromal-epithelial cocultures
ETS1 - Newly diagnosed and chronic pediatric immune thrombocytopenia: peripheral blood T-cells
ETS1 - Infant biliary atresia: liver
ETS1 - Telomere-elongated, prostate cancer cells
ETS1 - First-time acute myocardial infarction: peripheral blood
ETS1 - Neutrophil response to aerobic exercise
ETS1 - Head and neck squamous cell carcinoma tumors harboring human papillomavirus
ETS1 - Scleroderma-associated pulmonary hypertension: peripheral blood mononuclear cells
ETS1 - First-time acute myocardial infarction patients with or without recurrent event: peripheral blood
ETS1 - Peripheral blood monocyte response to Francisella tularensis infections
ETS1 - Liver transplantation tolerance: peripheral blood mononuclear cells
ETS1 - HIV envelope protein gp120 effect on activated B cells from healthy donors: time course
ETS1 - Natural killer cell response to interleukin-2 treatment: time course
ETS1 - Papillary thyroid cancer
ETS1 - SW480 KRAS-mutant colorectal cancer cell line response to dual inhibition of tankyrase and MEK: time course
ETS1 - Interleukin-21 effect on STAT3-deficient naïve B cells from autosomal dominant hyper IgE syndrome patients
ETS1 - Allergen inhalation challenge effect on peripheral blood of asthmatic early responders and dual responders
ETS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on